AR and prostate cancer: Furthermore, androgen independence is a feature of terminal stages in metastatic prostate cancer and the loss of AR expression in those cells appears to be at the transcriptional level (Tilley et al. 1990; Wolf et al. 1993) rather than involving deletion or mutation mechanisms (Dai et al. 1996).